ArticleCancer research2022

Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.

Patrick C O'Leary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.